Lisa M. Jenkins, Ph.D.

Senior Associate Scientist

Team Member of:

Dr. Jenkins obtained her Ph.D. in Biochemistry and Molecular Biology at the University of Georgia. She continued her research at the National Cancer Institute, applying mass spectrometry and biochemical methods to examine the regulation and functional consequences of p53 post-translational modification. Currently, Dr. Jenkins serves as Facility Manager for the Mass Spectrometry Resource within the Collaborative Protein Technology Resource. In this capability, she collaborates with CCR researchers by performing mass spectrometry experiments to further critical biological questions.

Areas of Expertise

1) mass spectrometry

Contact Info

Lisa M. Jenkins, Ph.D.
Center for Cancer Research
National Cancer Institute
Building 37, Room 2140
Bethesda, MD 20892
Ph: 240-760-7209
jenkinsl@mail.nih.gov

Selected Publications

  1. Thillainadesan G, Xiao H, Holla S, Dhakshnamoorthy J, Jenkins LMM, Wheeler D, Grewal SIS.
    Nat Commun. 11: 2412, 2020. [ Journal Article ]
  2. Jang SM, Nathans JF, Fu H, Redon CE, Jenkins LM, Thakur BL, Pongor LS, Baris AM, Gross JM, OʹNeill MJ, Indig FE, Cappell SD, Aladjem MI
    Nat Commun. 11: 24, 2020. [ Journal Article ]
  3. Bonner MK, Haase J, Swinderman J, Halas H, Miller Jenkins LM, Kelly AE.
    J Cell Biol. 218: 3237-3257, 2019. [ Journal Article ]
  4. Paul CD, Bishop K, Devine A, Paine EL, Staunton JR, Thomas SM, Thomas JR, Doyle AD, Miller Jenkins LM, Morgan NY, Sood R, Tanner K
    Cell Syst. 9: 187-206, 2019. [ Journal Article ]
  5. Miller Jenkins LM, Paine EL, Deshmukh L, Nikolayevskiy H, Lyons GC, Scerba MT, George Rosenker K, Luecke HF, Louis JM, Chertova E, Gorelick RJ, Ott DE, Clore GM, Appella DH
    J Am Chem Soc. 141: 8327-8338, 2019. [ Journal Article ]

Dr. Jenkins obtained her PhD in Biochemistry and Molecular Biology at the University of Georgia. She continued her research at the National Cancer Institute, applying mass spectrometry and biochemical methods to examine the regulation and functional consequences of p53 post-translational modification. Currently, Dr. Jenkins serves as Facility Manager for the Mass Spectrometry Resource within the Collaborative Protein Technology Resource. In this capability, she collaborates with CCR researchers by performing mass spectrometry experiments to further critical biological questions.